Chlorinated Tetralin Compounds and Pharmaceutical Compositions

USPTO granted patent US12599587B2 to Springworks Therapeutics, Inc. for chlorinated tetralin compounds and pharmaceutical compositions. The patent, classified under C07D 233/88 (heterocyclic compounds) and A61K 31/417 (medicinal preparations containing carbocyclic rings), contains 19 claims covering the novel compounds and their pharmaceutical formulations.

Affected parties including pharmaceutical companies, research institutions, and potential competitors should review the patent claims to assess potential licensing requirements, design-around opportunities, or freedom-to-operate considerations. The patent grant may impact ongoing R&D programs involving similar tetralin-based compounds or therapeutic applications in the covered patent classes.